Entity Common Stock, Shares Outstanding of Silo Pharma, Inc. from 10 Aug 2011 to 13 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Silo Pharma, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 10 Aug 2011 to 13 Nov 2025.
  • Silo Pharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 13 Nov 2025 was 13,318,273, a 197% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Silo Pharma, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 13,318,273 +8,833,817 +197% 13 Nov 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 9,401,128 +4,916,672 +110% 13 Aug 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 4,484,456 +1,640,822 +58% 26 Mar 2025 10-K 28 Mar 2025 2024 FY
Q3 2024 4,484,456 +1,375,659 +44% 12 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 4,484,456 +1,375,659 +44% 13 Aug 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 2,843,634 -315,163 -10% 23 Mar 2024 10-K 25 Mar 2024 2023 FY
Q3 2023 3,108,797 -30,000 -0.96% 13 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 3,108,797 -96,286,507 -97% 10 Aug 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 3,158,797 -95,513,173 -97% 23 Mar 2023 10-K 24 Mar 2023 2022 FY
Q3 2022 3,138,797 -95,533,173 -97% 10 Nov 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 99,395,304 +723,334 +0.73% 29 Jul 2022 10-Q 01 Aug 2022 2022 Q2
Q1 2022 98,671,970 +13,495,014 +16% 10 Mar 2022 10-K 28 Mar 2022 2021 FY
Q3 2021 98,671,970 +13,530,014 +16% 10 Nov 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 98,671,970 +13,530,014 +16% 11 Aug 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 85,176,956 +61,572,749 +261% 25 Mar 2021 10-K/A 17 May 2021 2020 FY
Q3 2020 85,141,956 +61,649,416 +262% 04 Nov 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 85,141,956 +61,674,416 +263% 12 Aug 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 23,604,207 +186,667 +0.8% 20 Mar 2020 10-K 20 Mar 2020 2019 FY
Q3 2019 23,492,540 -28,589,901 -55% 13 Nov 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 23,467,540 13 Aug 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 23,417,540 29 Mar 2019 10-K 04 Apr 2019 2018 FY
Q3 2018 52,082,441 14 Nov 2018 10-Q 14 Nov 2018 2018 Q3
Q1 2014 48,382,440 +17,751,240 +58% 31 Mar 2014 10-K 31 Mar 2014 2013 FY
Q3 2013 37,731,200 +7,100,000 +23% 14 Nov 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 30,731,200 +100,000 +0.33% 08 Aug 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 30,631,200 0 0% 05 Mar 2013 10-K 05 Mar 2013 2012 FY
Q3 2012 30,631,200 0 0% 12 Nov 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 30,631,200 0 0% 31 Jul 2012 10-Q 01 Aug 2012 2012 Q2
Q1 2012 30,631,200 09 May 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 30,631,200 25 Jan 2012 10-K 26 Jan 2012 2011 FY
Q3 2011 30,631,200 10 Nov 2011 10-Q 10 Nov 2011 2011 Q3
Q2 2011 30,631,200 10 Aug 2011 10-Q 15 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.